aluates Reports

$ 0.0

Automative

Global Gastrointestinal Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-29E15955

Gastrointestinal Therapeutics Global Market Insights and Sales Trends 2024

BUY CHAPTERS

Global Gastrointestinal Therapeutics Market Research Report 2025

Code: QYRE-Auto-29E15955

Report

September 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Allergan plc

Johnson & Johnson

Novartis

Pfizer Inc

Merck

F.Hoffmann-La Roche

Eli Lilly

Astrazeneca plc

Procter Gamble

Tillotts Pharma

GlaxoSmithKline PLC

Amgen Inc

Johnson & Johnson

Takeda

Gastrointestinal Therapeutics Market Size

The global market for Gastrointestinal Therapeutics was valued at US$ 38780 million in the year 2024 and is projected to reach a revised size of US$ 55390 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Gastrointestinal Therapeutics Market

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.

Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn"s disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics.

The Gastrointestinal Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastrointestinal Therapeutics Market Report

Report Metric	Details
Report Name	Gastrointestinal Therapeutics Market
Accounted market size in year	US$ 38780 million
Forecasted market size in 2031	US$ 55390 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Parenteral
Segment by Application	IBD Irritable Bowel Syndrome (IBS)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche, Eli Lilly, AstraZeneca, Procter & Gamble, Tillotts Pharma, GlaxoSmithKline, Amgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gastrointestinal Therapeutics Market growing?

Ans: The Gastrointestinal Therapeutics Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Gastrointestinal Therapeutics Market size in 2031?

Ans: The Gastrointestinal Therapeutics Market size in 2031 will be US$ 55390 million.

What is the Gastrointestinal Therapeutics Market share by application?

Ans: Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market.

Who are the main players in the Gastrointestinal Therapeutics Market report?

Ans: The main players in the Gastrointestinal Therapeutics Market are AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche, Eli Lilly, AstraZeneca, Procter & Gamble, Tillotts Pharma, GlaxoSmithKline, Amgen

What are the Application segmentation covered in the Gastrointestinal Therapeutics Market report?

Ans: The Applications covered in the Gastrointestinal Therapeutics Market report are IBD, Irritable Bowel Syndrome (IBS)

What are the Type segmentation covered in the Gastrointestinal Therapeutics Market report?

Ans: The Types covered in the Gastrointestinal Therapeutics Market report are Oral, Parenteral

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Parenteral

1.3 Market by Application

1.3.1 Global Gastrointestinal Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 IBD

1.3.3 Irritable Bowel Syndrome (IBS)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastrointestinal Therapeutics Market Perspective (2020-2031)

2.2 Global Gastrointestinal Therapeutics Growth Trends by Region

2.2.1 Global Gastrointestinal Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Gastrointestinal Therapeutics Market Dynamics

2.3.1 Gastrointestinal Therapeutics Industry Trends

2.3.2 Gastrointestinal Therapeutics Market Drivers

2.3.3 Gastrointestinal Therapeutics Market Challenges

2.3.4 Gastrointestinal Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastrointestinal Therapeutics Players by Revenue

3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gastrointestinal Therapeutics Revenue

3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio

3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2024

3.5 Global Key Players of Gastrointestinal Therapeutics Head office and Area Served

3.6 Global Key Players of Gastrointestinal Therapeutics, Product and Application

3.7 Global Key Players of Gastrointestinal Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Therapeutics Breakdown Data by Type

4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2026-2031)

5 Gastrointestinal Therapeutics Breakdown Data by Application

5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gastrointestinal Therapeutics Market Size (2020-2031)

6.2 North America Gastrointestinal Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gastrointestinal Therapeutics Market Size by Country (2020-2025)

6.4 North America Gastrointestinal Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastrointestinal Therapeutics Market Size (2020-2031)

7.2 Europe Gastrointestinal Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gastrointestinal Therapeutics Market Size by Country (2020-2025)

7.4 Europe Gastrointestinal Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Gastrointestinal Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gastrointestinal Therapeutics Market Size (2020-2031)

9.2 Latin America Gastrointestinal Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gastrointestinal Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Gastrointestinal Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Gastrointestinal Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Gastrointestinal Therapeutics Introduction

11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Gastrointestinal Therapeutics Introduction

11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction

11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Gastrointestinal Therapeutics Introduction

11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Gastrointestinal Therapeutics Introduction

11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Gastrointestinal Therapeutics Introduction

11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Gastrointestinal Therapeutics Introduction

11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.7.5 Merck Recent Development

11.8 F. Hoffmann-La Roche

11.8.1 F. Hoffmann-La Roche Company Details

11.8.2 F. Hoffmann-La Roche Business Overview

11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction

11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.8.5 F. Hoffmann-La Roche Recent Development

11.9 Eli Lilly

11.9.1 Eli Lilly Company Details

11.9.2 Eli Lilly Business Overview

11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction

11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.9.5 Eli Lilly Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction

11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.10.5 AstraZeneca Recent Development

11.11 Procter & Gamble

11.11.1 Procter & Gamble Company Details

11.11.2 Procter & Gamble Business Overview

11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction

11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.11.5 Procter & Gamble Recent Development

11.12 Tillotts Pharma

11.12.1 Tillotts Pharma Company Details

11.12.2 Tillotts Pharma Business Overview

11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction

11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.12.5 Tillotts Pharma Recent Development

11.13 Takeda

11.13.1 Takeda Company Details

11.13.2 Takeda Business Overview

11.13.3 Takeda Gastrointestinal Therapeutics Introduction

11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.13.5 Takeda Recent Development

11.14 GlaxoSmithKline

11.14.1 GlaxoSmithKline Company Details

11.14.2 GlaxoSmithKline Business Overview

11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction

11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.14.5 GlaxoSmithKline Recent Development

11.15 Amgen

11.15.1 Amgen Company Details

11.15.2 Amgen Business Overview

11.15.3 Amgen Gastrointestinal Therapeutics Introduction

11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2020-2025)

11.15.5 Amgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Allergan plc

Johnson & Johnson

Novartis

Pfizer Inc

Merck

F.Hoffmann-La Roche

Eli Lilly

Astrazeneca plc

Procter Gamble

Tillotts Pharma

GlaxoSmithKline PLC

Amgen Inc

Johnson & Johnson

Takeda

List of Tables

Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Parenteral

Table 4. Global Gastrointestinal Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gastrointestinal Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2020-2025)

Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2026-2031)

Table 10. Gastrointestinal Therapeutics Market Trends

Table 11. Gastrointestinal Therapeutics Market Drivers

Table 12. Gastrointestinal Therapeutics Market Challenges

Table 13. Gastrointestinal Therapeutics Market Restraints

Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gastrointestinal Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2024)

Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gastrointestinal Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Gastrointestinal Therapeutics, Product and Application

Table 21. Global Key Players of Gastrointestinal Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gastrointestinal Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gastrointestinal Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gastrointestinal Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gastrointestinal Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gastrointestinal Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gastrointestinal Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gastrointestinal Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gastrointestinal Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gastrointestinal Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. AbbVie Company Details

Table 47. AbbVie Business Overview

Table 48. AbbVie Gastrointestinal Therapeutics Product

Table 49. AbbVie Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 50. AbbVie Recent Development

Table 51. Allergan Company Details

Table 52. Allergan Business Overview

Table 53. Allergan Gastrointestinal Therapeutics Product

Table 54. Allergan Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Allergan Recent Development

Table 56. Johnson & Johnson Company Details

Table 57. Johnson & Johnson Business Overview

Table 58. Johnson & Johnson Gastrointestinal Therapeutics Product

Table 59. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Johnson & Johnson Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Gastrointestinal Therapeutics Product

Table 64. Takeda Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Gastrointestinal Therapeutics Product

Table 69. Novartis Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer Gastrointestinal Therapeutics Product

Table 74. Pfizer Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Merck Company Details

Table 77. Merck Business Overview

Table 78. Merck Gastrointestinal Therapeutics Product

Table 79. Merck Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Merck Recent Development

Table 81. F. Hoffmann-La Roche Company Details

Table 82. F. Hoffmann-La Roche Business Overview

Table 83. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product

Table 84. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 85. F. Hoffmann-La Roche Recent Development

Table 86. Eli Lilly Company Details

Table 87. Eli Lilly Business Overview

Table 88. Eli Lilly Gastrointestinal Therapeutics Product

Table 89. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Eli Lilly Recent Development

Table 91. AstraZeneca Company Details

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca Gastrointestinal Therapeutics Product

Table 94. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 95. AstraZeneca Recent Development

Table 96. Procter & Gamble Company Details

Table 97. Procter & Gamble Business Overview

Table 98. Procter & Gamble Gastrointestinal Therapeutics Product

Table 99. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Procter & Gamble Recent Development

Table 101. Tillotts Pharma Company Details

Table 102. Tillotts Pharma Business Overview

Table 103. Tillotts Pharma Gastrointestinal Therapeutics Product

Table 104. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Tillotts Pharma Recent Development

Table 106. Takeda Company Details

Table 107. Takeda Business Overview

Table 108. Takeda Gastrointestinal Therapeutics Product

Table 109. Takeda Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 110. Takeda Recent Development

Table 111. GlaxoSmithKline Company Details

Table 112. GlaxoSmithKline Business Overview

Table 113. GlaxoSmithKline Gastrointestinal Therapeutics Product

Table 114. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 115. GlaxoSmithKline Recent Development

Table 116. Amgen Company Details

Table 117. Amgen Business Overview

Table 118. Amgen Gastrointestinal Therapeutics Product

Table 119. Amgen Revenue in Gastrointestinal Therapeutics Business (2020-2025) & (US$ Million)

Table 120. Amgen Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Gastrointestinal Therapeutics Picture

Figure 2. Global Gastrointestinal Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gastrointestinal Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Parenteral Features

Figure 6. Global Gastrointestinal Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gastrointestinal Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. IBD Case Studies

Figure 9. Irritable Bowel Syndrome (IBS) Case Studies

Figure 10. Gastrointestinal Therapeutics Report Years Considered

Figure 11. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Gastrointestinal Therapeutics Market Share by Region: 2024 VS 2031

Figure 14. Global Gastrointestinal Therapeutics Market Share by Players in 2024

Figure 15. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2024

Figure 17. North America Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Gastrointestinal Therapeutics Market Share by Country (2020-2031)

Figure 19. United States Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gastrointestinal Therapeutics Market Share by Country (2020-2031)

Figure 23. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gastrointestinal Therapeutics Market Share by Region (2020-2031)

Figure 31. China Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gastrointestinal Therapeutics Market Share by Country (2020-2031)

Figure 39. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gastrointestinal Therapeutics Market Share by Country (2020-2031)

Figure 43. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 47. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 48. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 49. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 54. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 56. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 57. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 58. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 59. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 60. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Drugs Market Research Report 2025

Global Prescription Gastrointestinal Drugs Market Research Report 2024

Global Digestive Drugs Market Insights Forecast to 2030

Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal OTC Drugs Market Research Report 2024

Global OTC Gastrointestinal Products Market Research Report 2024

Global Gastrointestinal Rare Diseases Treatment Market Research Report 2025

Global Digestive Remedies Market Research Report 2024

Global OTC Digestives and Intestinal Remedies Market Research Report 2024

Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Cancer Devices Market Research Report 2024

Global Gastroenterology Devices Market Insights Forecast to 2030

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastrointestinal Bleeding Therapeutic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Device Market Research Report 2025

Global Gastrointestinal Bleeding Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions